RU2476891C2 - Идентификация молекул, модулирующих белок-белковое взаимодействие - Google Patents
Идентификация молекул, модулирующих белок-белковое взаимодействие Download PDFInfo
- Publication number
- RU2476891C2 RU2476891C2 RU2010112854/15A RU2010112854A RU2476891C2 RU 2476891 C2 RU2476891 C2 RU 2476891C2 RU 2010112854/15 A RU2010112854/15 A RU 2010112854/15A RU 2010112854 A RU2010112854 A RU 2010112854A RU 2476891 C2 RU2476891 C2 RU 2476891C2
- Authority
- RU
- Russia
- Prior art keywords
- protein
- reporter
- receptor
- protease
- activating
- Prior art date
Links
- 230000004850 protein–protein interaction Effects 0.000 title claims abstract description 43
- 238000004458 analytical method Methods 0.000 claims abstract description 97
- 230000000694 effects Effects 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 68
- 108090000623 proteins and genes Proteins 0.000 claims description 423
- 102000004169 proteins and genes Human genes 0.000 claims description 402
- 210000004027 cell Anatomy 0.000 claims description 197
- 108091005804 Peptidases Proteins 0.000 claims description 162
- 102000035195 Peptidases Human genes 0.000 claims description 161
- 239000004365 Protease Substances 0.000 claims description 156
- 235000019419 proteases Nutrition 0.000 claims description 142
- 238000003776 cleavage reaction Methods 0.000 claims description 113
- 230000007017 scission Effects 0.000 claims description 113
- 102000005962 receptors Human genes 0.000 claims description 107
- 108020003175 receptors Proteins 0.000 claims description 107
- 230000003213 activating effect Effects 0.000 claims description 105
- 108060001084 Luciferase Proteins 0.000 claims description 103
- 239000005089 Luciferase Substances 0.000 claims description 101
- 230000003993 interaction Effects 0.000 claims description 73
- 102000004190 Enzymes Human genes 0.000 claims description 58
- 108090000790 Enzymes Proteins 0.000 claims description 58
- 229940088598 enzyme Drugs 0.000 claims description 58
- 150000001875 compounds Chemical class 0.000 claims description 52
- 238000012360 testing method Methods 0.000 claims description 46
- 108091006027 G proteins Proteins 0.000 claims description 45
- 102000030782 GTP binding Human genes 0.000 claims description 45
- 108091000058 GTP-Binding Proteins 0.000 claims description 45
- 230000027455 binding Effects 0.000 claims description 43
- 230000008859 change Effects 0.000 claims description 30
- 108090000328 Arrestin Proteins 0.000 claims description 26
- 102000003916 Arrestin Human genes 0.000 claims description 26
- 102000037865 fusion proteins Human genes 0.000 claims description 25
- 108020001507 fusion proteins Proteins 0.000 claims description 25
- 239000012528 membrane Substances 0.000 claims description 24
- 238000004020 luminiscence type Methods 0.000 claims description 22
- 241000700605 Viruses Species 0.000 claims description 21
- 239000000758 substrate Substances 0.000 claims description 18
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 15
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 15
- 239000005090 green fluorescent protein Substances 0.000 claims description 14
- 241000208125 Nicotiana Species 0.000 claims description 13
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 13
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 claims description 10
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 claims description 10
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 claims description 10
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 8
- 230000001086 cytosolic effect Effects 0.000 claims description 7
- 210000001739 intranuclear inclusion body Anatomy 0.000 claims description 7
- 102000003992 Peroxidases Human genes 0.000 claims description 6
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 6
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 6
- 230000005945 translocation Effects 0.000 claims description 6
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 claims description 5
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 claims description 5
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 5
- 102000003675 cytokine receptors Human genes 0.000 claims description 5
- 108010057085 cytokine receptors Proteins 0.000 claims description 5
- 102000034287 fluorescent proteins Human genes 0.000 claims description 5
- 108091006047 fluorescent proteins Proteins 0.000 claims description 5
- 102000001301 EGF receptor Human genes 0.000 claims description 4
- 108060006698 EGF receptor Proteins 0.000 claims description 4
- 102000002464 Galactosidases Human genes 0.000 claims description 4
- 108010093031 Galactosidases Proteins 0.000 claims description 4
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 claims description 4
- 239000000488 activin Substances 0.000 claims description 4
- 210000003463 organelle Anatomy 0.000 claims description 4
- 230000008521 reorganization Effects 0.000 claims description 4
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 claims description 3
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 claims description 3
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 claims description 3
- 102000004400 Aminopeptidases Human genes 0.000 claims description 3
- 108090000915 Aminopeptidases Proteins 0.000 claims description 3
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 claims description 3
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 claims description 3
- 102000005367 Carboxypeptidases Human genes 0.000 claims description 3
- 108010006303 Carboxypeptidases Proteins 0.000 claims description 3
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 claims description 3
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 3
- 102000017944 Dishevelled Human genes 0.000 claims description 3
- 102000004980 Dopamine D2 Receptors Human genes 0.000 claims description 3
- 108090001111 Dopamine D2 Receptors Proteins 0.000 claims description 3
- 108010013369 Enteropeptidase Proteins 0.000 claims description 3
- 102100029727 Enteropeptidase Human genes 0.000 claims description 3
- 108010074860 Factor Xa Proteins 0.000 claims description 3
- 108010045438 Frizzled receptors Proteins 0.000 claims description 3
- 241000963438 Gaussia <copepod> Species 0.000 claims description 3
- 102000005741 Metalloproteases Human genes 0.000 claims description 3
- 108010006035 Metalloproteases Proteins 0.000 claims description 3
- 108010068563 PepT tripeptidase Proteins 0.000 claims description 3
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 claims description 3
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 claims description 3
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 claims description 3
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 claims description 3
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 claims description 3
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 claims description 3
- 108010022999 Serine Proteases Proteins 0.000 claims description 3
- 102000012479 Serine Proteases Human genes 0.000 claims description 3
- 101710097834 Thiol protease Proteins 0.000 claims description 3
- 108091005501 Threonine proteases Proteins 0.000 claims description 3
- 102000035100 Threonine proteases Human genes 0.000 claims description 3
- 108090000190 Thrombin Proteins 0.000 claims description 3
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 claims description 3
- 108010079452 beta Adrenergic Receptors Proteins 0.000 claims description 3
- 102000012740 beta Adrenergic Receptors Human genes 0.000 claims description 3
- 102000006635 beta-lactamase Human genes 0.000 claims description 3
- 108010021843 fluorescent protein 583 Proteins 0.000 claims description 3
- 102000048260 kappa Opioid Receptors Human genes 0.000 claims description 3
- 108010019813 leptin receptors Proteins 0.000 claims description 3
- 102000005861 leptin receptors Human genes 0.000 claims description 3
- 125000001151 peptidyl group Chemical group 0.000 claims description 3
- 235000019833 protease Nutrition 0.000 claims description 3
- 229960004072 thrombin Drugs 0.000 claims description 3
- 108020001588 κ-opioid receptors Proteins 0.000 claims description 3
- 102000005698 Frizzled receptors Human genes 0.000 claims description 2
- 108010008407 Muscarinic M2 Receptor Proteins 0.000 claims description 2
- 102000007205 Muscarinic M2 Receptor Human genes 0.000 claims description 2
- 108010059616 Activins Proteins 0.000 claims 2
- 102000005606 Activins Human genes 0.000 claims 2
- 102100024349 Alpha-1A adrenergic receptor Human genes 0.000 claims 2
- 102000004860 Dipeptidases Human genes 0.000 claims 2
- 108090001081 Dipeptidases Proteins 0.000 claims 2
- 108010075944 Erythropoietin Receptors Proteins 0.000 claims 2
- 102100036509 Erythropoietin receptor Human genes 0.000 claims 2
- 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 claims 2
- 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 claims 2
- 102000001617 Interferon Receptors Human genes 0.000 claims 2
- 108010054267 Interferon Receptors Proteins 0.000 claims 2
- 108010052090 Renilla Luciferases Proteins 0.000 claims 2
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims 2
- 102000002467 interleukin receptors Human genes 0.000 claims 2
- 108010093036 interleukin receptors Proteins 0.000 claims 2
- 102000003298 tumor necrosis factor receptor Human genes 0.000 claims 2
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 claims 1
- 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 claims 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 claims 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 claims 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 claims 1
- 108010092867 Transforming Growth Factor beta Receptors Proteins 0.000 claims 1
- 108010013122 serine receptor Proteins 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract description 22
- 239000003814 drug Substances 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 230000002779 inactivation Effects 0.000 abstract description 3
- 230000007515 enzymatic degradation Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 328
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 78
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 78
- 102000040430 polynucleotide Human genes 0.000 description 47
- 108091033319 polynucleotide Proteins 0.000 description 47
- 239000002157 polynucleotide Substances 0.000 description 47
- 108090000765 processed proteins & peptides Proteins 0.000 description 47
- 239000000556 agonist Substances 0.000 description 44
- 102000004196 processed proteins & peptides Human genes 0.000 description 38
- 239000003446 ligand Substances 0.000 description 37
- 102000000072 beta-Arrestins Human genes 0.000 description 35
- 108010080367 beta-Arrestins Proteins 0.000 description 34
- 229920001184 polypeptide Polymers 0.000 description 34
- 210000004899 c-terminal region Anatomy 0.000 description 28
- 102000039446 nucleic acids Human genes 0.000 description 27
- 108020004707 nucleic acids Proteins 0.000 description 27
- 150000007523 nucleic acids Chemical class 0.000 description 27
- 239000002245 particle Substances 0.000 description 26
- -1 for example Substances 0.000 description 24
- 238000001890 transfection Methods 0.000 description 23
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 20
- 108010076818 TEV protease Proteins 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 20
- 230000004927 fusion Effects 0.000 description 20
- 238000003556 assay Methods 0.000 description 19
- 239000012634 fragment Substances 0.000 description 19
- 229940039009 isoproterenol Drugs 0.000 description 18
- 239000005557 antagonist Substances 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 17
- 239000002773 nucleotide Substances 0.000 description 16
- 125000003729 nucleotide group Chemical group 0.000 description 16
- 108091008578 transmembrane receptors Proteins 0.000 description 16
- 102000027257 transmembrane receptors Human genes 0.000 description 16
- 102000017919 ADRB2 Human genes 0.000 description 15
- 101000959437 Homo sapiens Beta-2 adrenergic receptor Proteins 0.000 description 15
- 239000012190 activator Substances 0.000 description 15
- 230000004044 response Effects 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- 231100000673 dose–response relationship Toxicity 0.000 description 13
- 230000003834 intracellular effect Effects 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- 239000003550 marker Substances 0.000 description 11
- 230000001404 mediated effect Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 11
- 238000013518 transcription Methods 0.000 description 11
- 230000035897 transcription Effects 0.000 description 11
- 108010042653 IgA receptor Proteins 0.000 description 10
- 229930193140 Neomycin Natural products 0.000 description 10
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 229940125425 inverse agonist Drugs 0.000 description 10
- 229960004927 neomycin Drugs 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 230000008054 signal transmission Effects 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 9
- 230000019491 signal transduction Effects 0.000 description 9
- 229960002930 sirolimus Drugs 0.000 description 9
- 102100029648 Beta-arrestin-2 Human genes 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 101000807859 Homo sapiens Vasopressin V2 receptor Proteins 0.000 description 8
- 102100037108 Vasopressin V2 receptor Human genes 0.000 description 8
- 108010032967 beta-Arrestin 2 Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000013613 expression plasmid Substances 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 210000004940 nucleus Anatomy 0.000 description 8
- 230000037361 pathway Effects 0.000 description 8
- 230000011664 signaling Effects 0.000 description 8
- 230000002269 spontaneous effect Effects 0.000 description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 108091005703 transmembrane proteins Proteins 0.000 description 7
- 102000035160 transmembrane proteins Human genes 0.000 description 7
- 229940126649 ADRB2 agonist Drugs 0.000 description 6
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000002502 liposome Substances 0.000 description 6
- 230000017854 proteolysis Effects 0.000 description 6
- 102100024401 Alpha-1D adrenergic receptor Human genes 0.000 description 5
- 108090000331 Firefly luciferases Proteins 0.000 description 5
- 239000012097 Lipofectamine 2000 Substances 0.000 description 5
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 5
- 101710180012 Protease 7 Proteins 0.000 description 5
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 5
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 5
- 102000014384 Type C Phospholipases Human genes 0.000 description 5
- 108010079194 Type C Phospholipases Proteins 0.000 description 5
- 108010084455 Zeocin Proteins 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 210000004671 cell-free system Anatomy 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000012096 transfection reagent Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 102100037853 C-C chemokine receptor type 4 Human genes 0.000 description 4
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 4
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 4
- 102000017926 CHRM2 Human genes 0.000 description 4
- 102100020756 D(2) dopamine receptor Human genes 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 101000689685 Homo sapiens Alpha-1A adrenergic receptor Proteins 0.000 description 4
- 101000689696 Homo sapiens Alpha-1D adrenergic receptor Proteins 0.000 description 4
- 101000931901 Homo sapiens D(2) dopamine receptor Proteins 0.000 description 4
- 101000992298 Homo sapiens Kappa-type opioid receptor Proteins 0.000 description 4
- 101000928929 Homo sapiens Muscarinic acetylcholine receptor M2 Proteins 0.000 description 4
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 4
- 102100031819 Kappa-type opioid receptor Human genes 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
- 108700008625 Reporter Genes Proteins 0.000 description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000004031 partial agonist Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 102100029649 Beta-arrestin-1 Human genes 0.000 description 3
- 108010062466 Enzyme Precursors Proteins 0.000 description 3
- 102000010911 Enzyme Precursors Human genes 0.000 description 3
- 108010007005 Estrogen Receptor alpha Proteins 0.000 description 3
- 102100038595 Estrogen receptor Human genes 0.000 description 3
- 102000017911 HTR1A Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 101000822895 Homo sapiens 5-hydroxytryptamine receptor 1A Proteins 0.000 description 3
- 101001098560 Homo sapiens Proteinase-activated receptor 2 Proteins 0.000 description 3
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 3
- VFIDUCMKNJIJTO-BBRMVZONSA-N ICI 118551 Chemical compound CC(C)N[C@@H](C)[C@@H](O)COC1=CC=C(C)C2=C1CCC2 VFIDUCMKNJIJTO-BBRMVZONSA-N 0.000 description 3
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 3
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 3
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 102100037132 Proteinase-activated receptor 2 Human genes 0.000 description 3
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 3
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 3
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 108010032969 beta-Arrestin 1 Proteins 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 239000000833 heterodimer Substances 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 3
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- DUYSYHSSBDVJSM-KRWOKUGFSA-N sphingosine 1-phosphate Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O DUYSYHSSBDVJSM-KRWOKUGFSA-N 0.000 description 3
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- ZGGNJJJYUVRADP-ACJLOTCBSA-N 2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(Cl)C=CC=1)C1=CC=C(OCC(O)=O)C=C1 ZGGNJJJYUVRADP-ACJLOTCBSA-N 0.000 description 2
- 102000018918 Activin Receptors Human genes 0.000 description 2
- 108010052946 Activin Receptors Proteins 0.000 description 2
- 101150044281 Arr2 gene Proteins 0.000 description 2
- 102000036530 EDG receptors Human genes 0.000 description 2
- 108091007263 EDG receptors Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000015617 Janus Kinases Human genes 0.000 description 2
- 108010024121 Janus Kinases Proteins 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010002724 Pheromone Receptors Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000004136 Vasopressin Receptors Human genes 0.000 description 2
- 108090000643 Vasopressin Receptors Proteins 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 102000030621 adenylate cyclase Human genes 0.000 description 2
- 108060000200 adenylate cyclase Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 230000006916 protein interaction Effects 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 230000006337 proteolytic cleavage Effects 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 238000012289 standard assay Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 102000003808 Adiponectin Receptors Human genes 0.000 description 1
- 108090000179 Adiponectin Receptors Proteins 0.000 description 1
- 102400000059 Arg-vasopressin Human genes 0.000 description 1
- 101800001144 Arg-vasopressin Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000008081 Arrestins Human genes 0.000 description 1
- 108010074613 Arrestins Proteins 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 1
- 101100294108 Caenorhabditis elegans nhr-41 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 101710104441 FK506-binding protein 1 Proteins 0.000 description 1
- 101710132880 FK506-binding protein 1A Proteins 0.000 description 1
- 101710132879 FK506-binding protein 1B Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229940125633 GPCR agonist Drugs 0.000 description 1
- 102000008924 GPCR kinases Human genes 0.000 description 1
- 108050000878 GPCR kinases Proteins 0.000 description 1
- 102000027587 GPCRs class F Human genes 0.000 description 1
- 108091008884 GPCRs class F Proteins 0.000 description 1
- 102100030671 Gastrin-releasing peptide receptor Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 101150017422 HTR1 gene Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001010479 Homo sapiens Gastrin-releasing peptide receptor Proteins 0.000 description 1
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 101150009057 JAK2 gene Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101001010788 Mus musculus Endoribonuclease Proteins 0.000 description 1
- 101001010858 Mus musculus Endoribonuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 description 1
- 101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
- 102100026408 Peptidyl-prolyl cis-trans isomerase FKBP2 Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 241000242739 Renilla Species 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 102100022340 SHC-transforming protein 1 Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100024116 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MPT5 gene Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 102000007374 Smad Proteins Human genes 0.000 description 1
- 108010007945 Smad Proteins Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108091005735 TGF-beta receptors Proteins 0.000 description 1
- 108010040625 Transforming Protein 1 Src Homology 2 Domain-Containing Proteins 0.000 description 1
- 102100038344 Vomeronasal type-1 receptor 2 Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000971 adrenergic beta-2 receptor antagonist Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 108020001778 catalytic domains Proteins 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000000723 chemosensory effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000006395 clathrin-mediated endocytosis Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000011037 discontinuous sequential dilution Methods 0.000 description 1
- 238000003173 enzyme complementation Methods 0.000 description 1
- 238000003174 enzyme fragment complementation Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 108091005708 gustatory receptors Proteins 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 238000005734 heterodimerization reaction Methods 0.000 description 1
- 102000034345 heterotrimeric G proteins Human genes 0.000 description 1
- 108091006093 heterotrimeric G proteins Proteins 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 108010085650 interferon gamma receptor Proteins 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 230000006662 intracellular pathway Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000005937 nuclear translocation Effects 0.000 description 1
- 230000030648 nucleus localization Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 239000002427 pheromone receptor Substances 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000002005 protein protein interaction detection Methods 0.000 description 1
- 238000002762 protein-protein interaction assay Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 108091008691 sensory receptors Proteins 0.000 description 1
- 102000027509 sensory receptors Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000005737 synergistic response Effects 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96975607P | 2007-09-04 | 2007-09-04 | |
| US60/969,756 | 2007-09-04 | ||
| US8498708P | 2008-07-30 | 2008-07-30 | |
| US61/084,987 | 2008-07-30 | ||
| PCT/US2008/074543 WO2009032716A1 (en) | 2007-09-04 | 2008-08-28 | Identifying molecules that modulate protein- protein interactions using protease activated reporters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2010112854A RU2010112854A (ru) | 2011-10-10 |
| RU2476891C2 true RU2476891C2 (ru) | 2013-02-27 |
Family
ID=40029329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010112854/15A RU2476891C2 (ru) | 2007-09-04 | 2008-08-28 | Идентификация молекул, модулирующих белок-белковое взаимодействие |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8574865B2 (https=) |
| EP (1) | EP2191275B1 (https=) |
| JP (1) | JP5618829B2 (https=) |
| KR (1) | KR101636306B1 (https=) |
| CN (1) | CN102187225B (https=) |
| AU (1) | AU2008296501B2 (https=) |
| BR (1) | BRPI0816289B1 (https=) |
| CA (1) | CA2698362C (https=) |
| CL (1) | CL2008002602A1 (https=) |
| CY (1) | CY1113816T1 (https=) |
| DK (1) | DK2191275T3 (https=) |
| ES (1) | ES2393642T3 (https=) |
| IL (1) | IL204260A (https=) |
| MX (1) | MX2010002399A (https=) |
| MY (1) | MY155343A (https=) |
| PL (1) | PL2191275T3 (https=) |
| PT (1) | PT2191275E (https=) |
| RU (1) | RU2476891C2 (https=) |
| TW (1) | TWI425094B (https=) |
| UY (1) | UY31323A1 (https=) |
| WO (1) | WO2009032716A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2639539C2 (ru) * | 2015-12-29 | 2017-12-21 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Репортерная система на основе лентивирусных репортерных конструкций для изучения белок-белковых взаимодействий |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009032716A1 (en) * | 2007-09-04 | 2009-03-12 | Sanofi-Aventis | Identifying molecules that modulate protein- protein interactions using protease activated reporters |
| WO2014196932A1 (en) * | 2013-06-06 | 2014-12-11 | Agency For Science, Technology And Research | Protease-responsive peptide biosensors and methods for analyte detection |
| CA2930001A1 (en) | 2013-11-11 | 2015-05-14 | University Hospitals Cleveland Medical Center | Targeted treatment of anerobic cancer |
| CN107003323B (zh) | 2014-11-25 | 2019-06-04 | 文塔纳医疗系统公司 | 使用化学连接和半抗原转移的邻近测定法 |
| WO2016153880A2 (en) * | 2015-03-23 | 2016-09-29 | The Regents Of The University Of California | Methods for detection of rnase activity |
| US20180301048A1 (en) * | 2017-04-12 | 2018-10-18 | Age Of Learning, Inc. | Remote live tutoring platform |
| WO2020028381A1 (en) * | 2018-07-30 | 2020-02-06 | Montana Molecular, Llc | Biosensors for detecting arrestin signaling |
| JP2022513606A (ja) * | 2018-12-10 | 2022-02-09 | イエール ユニバーシティ | 宿主の生理機能を形成する微生物叢代謝産物 |
| JP2022551820A (ja) * | 2019-10-15 | 2022-12-14 | エフ．ホフマン－ラ ロシュ アーゲー | 細胞内または小胞内生体分子相互作用を検出するための人工膜貫通タンパク質 |
| WO2022259904A1 (ja) * | 2021-06-07 | 2022-12-15 | 国立研究開発法人理化学研究所 | プロテアーゼ活性測定用の融合タンパク質基質 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100934A1 (en) * | 2003-07-09 | 2005-05-12 | Lee Kevin J. | Method for assaying protein-protein interaction |
| US20060115871A1 (en) * | 2004-11-18 | 2006-06-01 | Washington State University | Protein interaction reporter agents and methods for using same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528271B1 (en) | 1997-06-05 | 2003-03-04 | Duke University | Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| US5891646A (en) | 1997-06-05 | 1999-04-06 | Duke University | Methods of assaying receptor activity and constructs useful in such methods |
| US7128915B2 (en) | 1997-09-18 | 2006-10-31 | Research Development Foundation | Membrane virus host range mutations and their uses as vaccine substrates |
| US6884870B2 (en) | 1998-03-20 | 2005-04-26 | California Institute Of Technology | Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells |
| US20030157553A1 (en) | 2000-03-03 | 2003-08-21 | Gabriel Berstein | Methods of assaying for G protein-coupled receptor ligands and modulators |
| EP1205191A1 (en) | 2000-11-13 | 2002-05-15 | Centre National De La Recherche Scientifique | Targeted modification of intracellular compounds |
| EP1353182A3 (en) | 2002-04-12 | 2004-02-04 | Smithkline Beecham Corporation | Method of predicting cell-based assay results using binding profiles |
| US20070224615A1 (en) * | 2003-07-09 | 2007-09-27 | Invitrogen Corporation | Methods for assaying protein-protein interactions |
| WO2009032716A1 (en) * | 2007-09-04 | 2009-03-12 | Sanofi-Aventis | Identifying molecules that modulate protein- protein interactions using protease activated reporters |
| EP3508570B1 (en) * | 2010-05-11 | 2020-07-22 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
-
2008
- 2008-08-28 WO PCT/US2008/074543 patent/WO2009032716A1/en not_active Ceased
- 2008-08-28 CA CA 2698362 patent/CA2698362C/en not_active Expired - Fee Related
- 2008-08-28 BR BRPI0816289A patent/BRPI0816289B1/pt not_active IP Right Cessation
- 2008-08-28 JP JP2010524099A patent/JP5618829B2/ja not_active Expired - Fee Related
- 2008-08-28 PT PT08829659T patent/PT2191275E/pt unknown
- 2008-08-28 EP EP20080829659 patent/EP2191275B1/en active Active
- 2008-08-28 CN CN200880110461.7A patent/CN102187225B/zh active Active
- 2008-08-28 ES ES08829659T patent/ES2393642T3/es active Active
- 2008-08-28 AU AU2008296501A patent/AU2008296501B2/en active Active
- 2008-08-28 DK DK08829659T patent/DK2191275T3/da active
- 2008-08-28 RU RU2010112854/15A patent/RU2476891C2/ru not_active IP Right Cessation
- 2008-08-28 MX MX2010002399A patent/MX2010002399A/es active IP Right Grant
- 2008-08-28 MY MYPI2010000555A patent/MY155343A/en unknown
- 2008-08-28 US US12/676,284 patent/US8574865B2/en active Active
- 2008-08-28 KR KR1020107004803A patent/KR101636306B1/ko not_active Expired - Fee Related
- 2008-08-28 PL PL08829659T patent/PL2191275T3/pl unknown
- 2008-09-02 CL CL2008002602A patent/CL2008002602A1/es unknown
- 2008-09-04 TW TW97133835A patent/TWI425094B/zh not_active IP Right Cessation
- 2008-09-04 UY UY31323A patent/UY31323A1/es not_active Application Discontinuation
-
2010
- 2010-03-02 IL IL204260A patent/IL204260A/en not_active IP Right Cessation
-
2012
- 2012-11-08 CY CY20121101062T patent/CY1113816T1/el unknown
-
2013
- 2013-10-02 US US14/044,250 patent/US9023610B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100934A1 (en) * | 2003-07-09 | 2005-05-12 | Lee Kevin J. | Method for assaying protein-protein interaction |
| US20060115871A1 (en) * | 2004-11-18 | 2006-06-01 | Washington State University | Protein interaction reporter agents and methods for using same |
Non-Patent Citations (3)
| Title |
|---|
| IGOR STAGLJAR et al., A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo, Proc. Natl. Acad. Sci. USA April 1998, Vol.95, pp.5187-5192. * |
| IGOR STAGLJAR et al., A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo, Proc. Natl. Acad. Sci. USA April 1998, Vol.95, pp.5187-5192. MICHAEL C. WEHR et al., Monitoring regulated protein-protein interactions using split TEV, Nature Methods. Vol.3, no.12, 2006 pp.985-93. * |
| MICHAEL C. WEHR et al., Monitoring regulated protein-protein interactions using split TEV, Nature Methods. Vol.3, no.12, 2006 pp.985-93. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2639539C2 (ru) * | 2015-12-29 | 2017-12-21 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Репортерная система на основе лентивирусных репортерных конструкций для изучения белок-белковых взаимодействий |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2476891C2 (ru) | Идентификация молекул, модулирующих белок-белковое взаимодействие | |
| US8017398B2 (en) | Method for assaying protein-protein interaction | |
| EP2002021B1 (en) | Methods for assaying protein-protein interaction | |
| US20070224615A1 (en) | Methods for assaying protein-protein interactions | |
| EP1893627A1 (en) | Multiplex array useful for assaying protein-protein interaction | |
| US20060148007A1 (en) | Method for using division arrested cells in screening assays | |
| HK1162664B (en) | Identifying molecules that modulate protein- protein interactions using protease activated reporters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180829 |